0.44  -0.021 (-4.49%)		10-15 16:00
Open: 0.465 High: 0.465 Volume: 389,399		Pre. Close: 0.4607 Low: 0.43 Market Cap: 47(M)

Short term
Mid term
Targets	6-month :	0.72	1-year :	0.86
Resists	First :	0.62	Second :	0.74
Pivot price	0.58
Supports	First :	0.43	Second :	0.35
MAs	MA(5) :	0.48	MA(20) :	0.59
	MA(100) :	0.64	MA(250) :	0.61
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	3.9	D(3) :	3.4
RSI	RSI(14): 28.8
52-week	High :	0.93	Low :	0.4

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ VNRX ] has closed above bottom band by 5.5%. Bollinger Bands are 79.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	0.47 - 0.47	0.47 - 0.47
Low:	0.42 - 0.43	0.43 - 0.43
Close:	0.43 - 0.44	0.44 - 0.44

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.

Thu, 16 Oct 2025
Volitionrx (VNRX) president Reynolds buys $56,100 in shares By Investing.com - Investing.com South Africa

Wed, 15 Oct 2025
Still buys VolitionRx (VNRX) shares and warrants for $24,518 - Investing.com

Wed, 15 Oct 2025
Volitionrx (VNRX) president Reynolds buys $56,100 in shares - Investing.com

Wed, 15 Oct 2025
Volitionrx director Innes buys $49k in shares - Investing.com

Fri, 10 Oct 2025
VolitionRx Prices Public Offering Of 11.55 Mln Shares And Warrants At $0.52/set; Shares Fall - Nasdaq

Fri, 10 Oct 2025
$6.0M Gross Proceeds — VolitionRx Prices 11.55M Shares & Warrants; Close Expected Oct 14, 2025 - Stock Titan

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: AMEX
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Shares Out	0 (M)
Shares Float	92 (M)
Held by Insiders	7.257e+007 (%)
Held by Institutions	21.4 (%)
Shares Short	382 (K)
Shares Short P.Month	0 (K)

EPS	-3.164e+007
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	-1 %
Return on Assets (ttm)	766.1 %
Return on Equity (ttm)	-100.9 %
Qtrly Rev. Growth	976520 %
Gross Profit (p.s.)	74.77
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	-0.5 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	-17 (M)

PE Ratio	-0.01
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	-1.88

Dividend	0
Forward Dividend	448930
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.